Detection of Tropheryma whipplei DNA in feces by PCR using a target capture method
- PMID: 12089263
- PMCID: PMC120552
- DOI: 10.1128/JCM.40.7.2466-2471.2002
Detection of Tropheryma whipplei DNA in feces by PCR using a target capture method
Abstract
Whipple's disease is a rare multisystemic bacterial infection with variable clinical manifestations. For decades, the laboratory diagnosis was based on the demonstration of periodic acid Schiff-positive inclusions in macrophages of gastrointestinal biopsies. PCR has improved the diagnosis of Whipple's disease due to its increased sensitivity compared to histopathological analysis. To avoid invasive procedures for taking specimens, we have investigated the possibility of detecting Tropheryma whipplei DNA in feces rather than in biopsies or gastric aspirate of patients with and without Whipple's disease. Total bacterial DNA was isolated from stool specimens using Qiagen columns followed by a T. whipplei-specific hybridization step with a biotinylated capture probe and streptavidin-coated magnetic particles. The captured DNA was then amplified using the same seminested PCR targeting the 16S rRNA gene of the organism that had been applied to other specimens without capturing. For five of eight patients with Whipple's disease, duodenal biopsies and stool samples were PCR positive, whereas for the three other patients, both specimens were PCR negative. Of 84 patients without Whipple's disease, 75 tested negative in the duodenal biopsy and in the stool sample. For four, both specimens were positive. Five patients tested positive in the stool sample but not in the biopsy. However, for three of these five patients, the gastric aspirate had been PCR positive, indicating that the stool PCR result was true rather than false positive. Compared to PCR from duodenal biopsies, stool PCR has a sensitivity of 100% and a specificity of 97.3%. Additionally, 15 PCR-positive and 22 PCR-negative stool samples were extracted using the Invisorb Spin Stool DNA kit. The simplified stool extraction showed 93.3% sensitivity and 95.5% specificity compared to the target capture method. We conclude that PCR with stool specimens with either extraction method is a sensitive and specific diagnostic tool for the detection of T. whipplei DNA and one not requiring invasive sampling procedures.
Figures
Similar articles
-
Detection of Tropheryma whipplei in stool samples by one commercial and two in-house real-time PCR assays.Trop Med Int Health. 2019 Jan;24(1):101-108. doi: 10.1111/tmi.13172. Epub 2018 Nov 8. Trop Med Int Health. 2019. PMID: 30347125
-
Genotyping reveals a wide heterogeneity of Tropheryma whipplei.Microbiology (Reading). 2008 Feb;154(Pt 2):521-527. doi: 10.1099/mic.0.2007/011668-0. Microbiology (Reading). 2008. PMID: 18227256
-
Diagnosis and follow-up of Whipple's disease by amplification of the 16S rRNA gene of Tropheryma whippelii.Eur J Clin Microbiol Infect Dis. 1999 Jan;18(1):62-5. doi: 10.1007/s100960050228. Eur J Clin Microbiol Infect Dis. 1999. PMID: 10192717
-
Whipple's disease and "Tropheryma whippelii".Clin Microbiol Rev. 2001 Jul;14(3):561-83. doi: 10.1128/CMR.14.3.561-583.2001. Clin Microbiol Rev. 2001. PMID: 11432814 Free PMC article. Review.
-
[Whipple's disease and Tropheryma whipplei infections in internal medicine. When to think about it? How to treat?].Rev Med Interne. 2014 Dec;35(12):801-7. doi: 10.1016/j.revmed.2014.04.016. Epub 2014 Jun 2. Rev Med Interne. 2014. PMID: 24933290 Review. French.
Cited by
-
Connecting the dots: the many systemic manifestations of whipple disease.Gastroenterol Hepatol (N Y). 2012 Jan;8(1):63-6. Gastroenterol Hepatol (N Y). 2012. PMID: 22347837 Free PMC article. No abstract available.
-
Whipple's Disease (WD) Without Arthropathy in an Immunocompromised Patient.Cureus. 2022 Nov 18;14(11):e31659. doi: 10.7759/cureus.31659. eCollection 2022 Nov. Cureus. 2022. PMID: 36545168 Free PMC article.
-
Short-Term Amoxicillin Clavulanate in the Treatment of Pulmonary Abscess Caused by Tropheryma whipplei Infection Diagnosed by Targeted Next-Generation Sequencing: A Case Report and Literature Review.Infect Drug Resist. 2024 Oct 23;17:4607-4616. doi: 10.2147/IDR.S488740. eCollection 2024. Infect Drug Resist. 2024. PMID: 39464838 Free PMC article.
-
Whipple's disease.Curr Gastroenterol Rep. 2003 Oct;5(5):379-85. doi: 10.1007/s11894-003-0050-6. Curr Gastroenterol Rep. 2003. PMID: 12959718 Review.
-
High-throughput sequencing of 16S rDNA amplicons characterizes bacterial composition in cerebrospinal fluid samples from patients with purulent meningitis.Drug Des Devel Ther. 2015 Aug 7;9:4417-29. doi: 10.2147/DDDT.S82728. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26300628 Free PMC article.
References
-
- Altwegg, M., A. Fleisch-Marx, D. Goldenberger, S. Hailemariam, A. Schaffner, and R. Kissling. 1996. Spondylodiscitis caused by Tropheryma whippelii. Schweiz. Med. Wochenschr. 126:1495-1499. - PubMed
-
- Brändle, M., P. Ammann, G. A. Spinas, F. Dutly, R. L. Galeazzi, C. Schmid, and M. Altwegg. 1999. Relapsing Whipple's disease presenting with hypopituitarism. Clin. Endocrinol. 50:399-403. - PubMed
-
- Brühlmann, P., B. A. Michel, and M. Altwegg. 2000. Diagnosis and therapy monitoring of Whipple's arthritis by polymerase chain reaction. Rheumatology 39:1427-1428. - PubMed
-
- Dauga, C., I. Miras, and P. A. Grimont. 1997. Strategy for detection and identification of bacteria based on 16S rRNA genes in suspected cases of Whipple's disease. J. Med. Microbiol. 46:340-347. - PubMed
-
- Dobbins, W. O., III. 1987. Whipple's disease. Charles C. Thomas, Springfield, Ill.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources